U.S./EU collaboration for global health policy issues called for by Institute for Alternative Futures.
U.S./EUROPEAN UNION COLLABORATION ON STANDARDS SETTING and public health issues should be a priority for the U.S., Institute for Alternative Futures Chairman Willis Goldbeck told the United States Pharmacopeial Convention Quinquennial Meeting March 9 in Washington, D.C. "We have an obligation in the U.S., if we are serious, if we are here for the advancement of health and not just for the matters of the moment, to listen and learn as well as share" with Europe on public health policy, he stated.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth